Do no do examples

Do no do examples for Epilepsies: diagnosis and management
Title Year published Impact Level
An electroencephalogram (EEG) should not be performed in the case of probable syncope because of the possibility of a false-positive result. June 2016 Unclassified
An electroencephalogram (EEG) should not be used to exclude a diagnosis of epilepsy in a child, young person or adult in whom the clinical presentation supports a diagnosis of a nonepileptic event. June 2016 Unclassified
Repeated standard EEGs should not be used in preference to sleep or sleepdeprived EEGs. June 2016 Unclassified
Neuroimaging should not be routinely requested when a diagnosis of idiopathic generalised epilepsy has been made. June 2016 Unclassified
Measurement of serum prolactin is not recommended for the diagnosis of epilepsy. June 2016 Unclassified
Do not offer carbamazepine, gabapentin, oxcarbazepine, phenytoin, pregabalin, tiagabine or vigabatrin if there are absence or myoclonic seizures, or if Juvenile myoclonic epilepsy (JME) is suspected. June 2016 Unclassified
Do not offer carbamazepine, gabapentin, oxcarbazepine, phenytoin, pregabalin, tiagabine or vigabatrin as adjunctive treatment in children, young people and adults with absence seizures. June 2016 Unclassified
Do not offer carbamazepine, gabapentin, oxcarbazepine, phenytoin, pregabalin, tiagabine or vigabatrin as adjunctive treatment in children, young people and adults with myoclonic seizures. June 2016 Unclassified
Do not offer carbamazepine, gabapentin, oxcarbazepine, pregabalin, tiagabine or vigabatrin as adjunctive treatment in children, young people and adults with tonic or atonic seizures. June 2016 Unclassified
Do not offer carbamazepine, gabapentin, lamotrigine, oxcarbazepine, phenytoin, pregabalin, tiagabine or vigabatrin as adjunctive treatment in children, young people and adults with Dravet syndrome. June 2016 Unclassified
Only offer felbamate in centres providing tertiary epilepsy specialist care and when treatment with sodium valproate, lamotrigine, rufinamide and topiramate have proven ineffective or not tolerated. June 2016 Unclassified
Do not offer carbamazepine, gabapentin, oxcarbazepine, pregabalin, tiagabine or vigabatrin as adjunctive treatment in children, young people and adults with Lennox–Gastaut syndrome. June 2016 Unclassified
Levetiracetam is not cost effective at June 2011 unit costs June 2016 Unclassified
Do not offer carbamazepine, gabapentin, oxcarbazepine, phenytoin, pregabalin, tiagabine or vigabatrin as adjunctive treatment in children, young people and adults with Idiopathic Generalized Epilepsies (IGE). June 2016 Unclassified
Do not offer carbamazepine, gabapentin, oxcarbazepine, phenytoin, pregabalin, tiagabine or vigabatrin as Adjunctive treatment in children, young people and adults with juvenile myoclonic epilepsy (JME). June 2016 Unclassified
Do not offer carbamazepine, gabapentin, oxcarbazepine, phenytoin, pregabalin, tiagabine or vigabatrin as adjunctive treatment in children, young people and adults with childhood absence epilepsy, juvenile absence epilepsy or other absence epilepsy syndromes. June 2016 Unclassified
Regular blood test monitoring in adults with epilepsy is not recommended as routine, and should be done only if clinically indicated. June 2016 Unclassified
Psychological interventions may be used as adjunctive therapy in epilepsy. They have not been proven to affect seizure frequency and are not an alternative to pharmacological treatment. June 2016 Unclassified
Do not routinely monitor anti-epileptic drug (AED) levels during pregnancy. If seizures increase or are likely to increase, monitoring AED levels (particularly levels of lamotrigine and phenytoin, which may be particularly affected in pregnancy) may be useful when making dose adjustments. June 2016 Unclassified
An electroencephalogram (EEG) should be performed only to support a diagnosis of epilepsy in adults in whom the clinical history suggests that the seizure is likely to be epileptic in origin. June 2016 Unclassified
An electroencephalogram (EEG) should be performed only to support a diagnosis of epilepsy in children and young people. If an EEG is considered necessary, it should be performed after the second epileptic seizure but may, in certain circumstances, as evaluated by the specialist, be considered after a first epileptic seizure. June 2016 Unclassified
Regular blood test monitoring in children and young people is not recommended as routine, and should be done only if clinically indicated and recommended by the specialist. June 2016 Unclassified
Only prescribe buccal midazolam or rectal diazepam for use in the community for children, young people and adults who have had a previous episode of prolonged or serial convulsive seizures. June 2016 Unclassified
There is insufficient evidence to recommend the routine use of joint epilepsy and obstetric clinics, although they may be convenient for mothers and healthcare professionals. June 2016 Unclassified
Anti-epileptic drug therapy should only be started once the diagnosis of epilepsy is confirmed, except in exceptional circumstances that require discussion and agreement between the prescriber, the specialist and the child, young person or adult and their family and/or carers as appropriate. June 2016 Unclassified
An EEG should not be performed in the case of probable syncope because of the possibility of a false-positive result. January 2012 Unclassified
The EEG should not be used to exclude a diagnosis of epilepsy in a child, young person or adult in whom the clinical presentation supports a diagnosis of a non-epileptic event. January 2012 Unclassified
Repeated standard EEGs should not be used in preference to sleep or sleepdeprived EEGs. January 2012 Unclassified
Neuroimaging should not be routinely requested when a diagnosis of idiopathic generalised epilepsy has been made. January 2012 Unclassified
Measurement of serum prolactin is not recommended for the diagnosis of epilepsy. January 2012 Unclassified
If there are absence or myoclonic seizures, or if JME is suspected, do not offer carbamazepine, gabapentin, oxcarbazepine, phenytoin, pregabalin, tiagabine or vigabatrin. January 2012 Unclassified
Adjunctive treatment in children, young people and adults with myoclonic seizures Do not offer carbamazepine, gabapentin, oxcarbazepine, phenytoin, pregabalin, tiagabine or vigabatrin. January 2012 Unclassified
Adjunctive treatment in children, young people and adults with tonic or atonic seizures Do not offer carbamazepine, gabapentin, oxcarbazepine, pregabalin, tiagabine or vigabatrin. January 2012 Unclassified
Adjunctive treatment in children, young people and adults with Dravet syndrome Do not offer carbamazepine, gabapentin, lamotrigine, oxcarbazepine, phenytoin, pregabalin, tiagabine or vigabatrin. January 2012 Unclassified
Adjunctive treatment in children, young people and adults with Lennox Gastaut syndrome Do not offer carbamazepine, gabapentin, oxcarbazepine, pregabalin, tiagabine or vigabatrin. January 2012 Unclassified
First-line treatment in children and young people with benign epilepsy with centrotemporal spikes, Panayiotopoulos syndrome or late-onset childhood occipital epilepsy (Gastaut type) Levetiracetam is not cost effective at June 2011 unit costs. Offer levetiracetam, oxcarbazepine or sodium valproate (provided the acquisition cost of levetiracetam falls to at least 50% of June 2011 value documented in the National Health Service Drug Tariff for England and Wales) if carbamazepine and lamotrigine are unsuitable or not tolerated January 2012 Unclassified
Adjunctive treatment in children, young people and adults with idiopathic generalised epilepsy (IGE) Do not offer carbamazepine, gabapentin, oxcarbazepine, phenytoin, pregabalin, tiagabine or vigabatrin. January 2012 Unclassified
Adjunctive treatment in children, young people and adults with juvenile myoclonic epilepsy (JME) Do not offer carbamazepine, gabapentin, oxcarbazepine, phenytoin, pregabalin, tiagabine or vigabatrin. January 2012 Unclassified
Adjunctive treatment in children, young people and adults with childhood absence epilepsy, juvenile absence epilepsy or other absence epilepsy syndromes Do not offer carbamazepine, gabapentin, oxcarbazepine, phenytoin, pregabalin, tiagabine or vigabatrin. January 2012 Unclassified
Regular blood test monitoring in adults is not recommended as routine, and should be done only if clinically indicated. [2004] January 2012 Unclassified
Regular blood test monitoring in children and young people is not recommended as routine, and should be done only if clinically indicated and recommended by the specialist. [2004] January 2012 Unclassified
The progestogen-only pill is not recommended as reliable contraception in women and girls taking enzyme-inducing anti epileptic drugs (AEDs). January 2012 Unclassified
Do not routinely monitor anti epileptic drug (AED) levels during pregnancy. If seizures increase or are likely to increase, monitoring AED levels (particularly levels of lamotrigine and phenytoin, which may be particularly affected in pregnancy) may be useful when making dose adjustments. January 2012 Unclassified
Levetiracetam is not cost effective at June 2011 unit costs. Offerlevetiracetam, oxcarbazepine or sodium valproate (provided the acquisitioncost of levetiracetam falls to at least 50% of June 2011 value documented inthe National Health Service Drug Tariff for England and Wales) if carbamazepine and lamotrigine are unsuitable or not tolerated. January 2012 Unclassified